Huntington Bancshares Incorporated
At today's price, Huntington Bancshares Incorporated (HBAN) is priced for 12.7% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Huntington has roughly doubled its balance sheet through the Cadence and Veritex deals, pushing average loans up 33% year over year to $174.2 billion and net interest income up the same 33% to about $1.91 billion fully-taxable equivalent. [Source: HBAN Q1 2026 earnings release] • The share count has been climbing at about a 6.7% annual pace, the cost of buying that scale with stock, so per-share earnings have to outrun the dilution before holders see the benefit. • Watch the new $3 billion rep
Is HBAN overvalued? See what's priced in →
1,112 institutional managers reported holding HBAN in 13F filings for the quarter ended 2026-03-31. Together they hold about 90% of the company; the top 10 hold 52%. 164 opened new positions that quarter. Held by Vanguard Group, BlackRock, Wellington Management, among others. On the short side, 78.0M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (3.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
HBAN's share count grew 66.2% over the past five years even with $800.00M spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.62 a share annually. Cash returned over the past three years: $2.51B in dividends and $150.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at HBAN over the trailing three years: 2025: 1 buy totaling $100k; 2026: 10 buys totaling $1.44M. 33 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
HBAN's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-29 | -0.7% | -14.4% |
| 2023-10-28 | -3.7% | +34.7% |
| 2024-02-17 | +1.1% | +3.3% |
| 2024-05-01 | +0.8% | -4.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
HBAN's latest 8-K filings: 2026-06-25 (items 8.01, 9.01); 2026-06-08 (items 7.01, 9.01); 2026-05-27 (items 7.01, 9.01); 2026-04-24 (items 5.07); 2026-04-23 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.